Development of Antidrug Antibodies in Multiple Sclerosis Cohorts in Europe - Overview of Interferon Beta and Natalizumab Cases Tested for ADA in Different Countries
Journal article published in 2014 by
Jenny Link,
Michael Auer,
Claudia Sievers,
Poul Erik Hyldgaard Jensen,
Clemens Warnke 
,
Kathleen Wolffram,
Ryan Ramanujam,
Bernd Kieseier,
Per Soelberg Soerensen,
Raija Lindberg,
Florian Deisenhammer,
Pierre Donnes,
Andy Lawton,
Julie Davidson,
Anna Fogdell-Hahn
,
Kathleen Wolffram,
Ryan Ramanujam,
Bernd Kieseier,
Per Soelberg Soerensen,
Raija Lindberg,
Florian Deisenhammer,
Pierre Donnes,
Andy Lawton,
Julie Davidson,
Anna Fogdell-Hahn
